News Archives | Page 8 of 14 | American Parkinson Disease Association

The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease

Posted on January 8, 2020July 15, 2024 by Rebecca Gilbert, MD, Ph.D.

The FDA recently approved Fluorodopa...see more F18 (F-Dopa), a radioactive tracer for positron emission tomography (PET) that can help visualize the nerve endings of dopaminergic neurons. It can be used to help in the diagnosis of Parkinson’s disease (PD) and other parkinsonian […]

Deep brain stimulation and swimming

Posted on December 4, 2019December 4, 2019 by APDA

Deep brain stimulation (DBS) is a surgical treatment for Parkinson’s disease (PD) symptoms in...see more which small wires are inserted deep into the brain to deliver electrical current that allows for maintenance of more normal movement. DBS is particularly helpful for those with medication-resistant tremors as well as for those who […]

Promising results from the University of Pittsburgh APDA Center for Advanced Research

Posted on October 24, 2019July 13, 2023 by APDA

Building off of pivotal APDA-funded work highlighted...see more here, Dr. J. Timothy Greenamyre and his team, published a new study investigating the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease (PD). LRRK2 is known to be mutated in a small […]

Taking Parkinson’s education to the farmers market: educating under-served communities

Posted on September 16, 2019April 24, 2024 by APDA

Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian...see more Medical Center in New York City, attended APDA’s Diversity in Parkinson’s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi had just spent the day learning about health care disparities in PD care, low […]

New medication, Istradefylline, gets approved for Parkinson’s disease

Posted on September 4, 2019July 13, 2023 by APDA

On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […]

APDA Seed Funding Leads to Prestigious NIH Research Grant

Posted on August 16, 2019July 13, 2023 by APDA

APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research...see more Grant awardee on receiving a recently-awarded National Institutes of Health (NIH) R21 grant.

APDA-funded research finds new role for alpha-synuclein

Posted on July 30, 2019July 13, 2023 by APDA

This new understanding of alpha-synuclein’s function could open up new ways of thinking...see more about treatments for Parkinson's disease.

Merck announces its decision to stop the manufacturing of Sinemet CR

Posted on July 17, 2019July 30, 2019 by APDA

Merck has informed the Food and Drug Administration (FDA)...see more that it will discontinue the manufacturing of Sinemet CR (controlled release).

Bill Rasmussen, founder of ESPN, diagnosed with Parkinson’s disease

Posted on July 15, 2019 by APDA

Bill Rasmussen, founder of ESPN, shares his Parkinson's disease diagnoses.

$52 billion per year is spent on PD-related expenses, according to results of the Economic Burden of Parkinson’s Disease Study

Posted on June 13, 2019July 13, 2023 by Rebecca Gilbert, MD, Ph.D.

$52 billion per year is spent on PD-related expenses, according to results of the Economic Burden of Parkinson’s Disease...see more Study In October 2018, APDA asked our constituents to consider participating in a new study called The Economic Burden of Parkinson’s Disease (PD), with the goal of estimating the economic burden of PD in the United […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Important News & Updates from APDA

The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease

Deep brain stimulation and swimming

Promising results from the University of Pittsburgh APDA Center for Advanced Research

Taking Parkinson’s education to the farmers market: educating under-served communities

New medication, Istradefylline, gets approved for Parkinson’s disease

APDA Seed Funding Leads to Prestigious NIH Research Grant

APDA-funded research finds new role for alpha-synuclein

Merck announces its decision to stop the manufacturing of Sinemet CR

Bill Rasmussen, founder of ESPN, diagnosed with Parkinson’s disease

$52 billion per year is spent on PD-related expenses, according to results of the Economic Burden of Parkinson’s Disease Study

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!